NASDAQ:CMAX - CareMax Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.40
  • Forecasted Upside: 41.79 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$8.04
▲ +0.03 (0.37%)

This chart shows the closing price for CMAX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CareMax Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CMAX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CMAX

Analyst Price Target is $11.40
▲ +41.79% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for CareMax in the last 3 months. The average price target is $11.40, with a high forecast of $15.00 and a low forecast of $8.00. The average price target represents a 41.79% upside from the last price of $8.04.

This chart shows the closing price for CMAX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in CareMax.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/19/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/15/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/13/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/14/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/13/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/12/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/17/2022UBS GroupLower Price TargetNA$12.00Medium
5/11/2022CowenLower Price Target$11.00 ➝ $8.00Low
5/11/2022CowenLower Price Target$11.00 ➝ $8.00High
1/7/2022UBS GroupInitiated CoverageBuy$14.00High
10/20/2021Jefferies Financial GroupInitiated CoverageBuy$15.00Medium
9/13/2021Piper SandlerUpgradeNeutral ➝ Overweight$14.00High
9/9/2021CowenInitiated CoverageOutperform$14.00High
7/1/2021Piper SandlerInitiated CoverageNeutral$14.00High
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.51 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/14/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/13/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/15/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/14/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/14/2022
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/13/2022
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/12/2022

Current Sentiment

  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
CareMax logo
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
Read More

Today's Range

Now: $8.04
Low: $7.81
High: $8.25

50 Day Range

MA: $5.68
Low: $3.62
High: $8.04

52 Week Range

Now: $8.04
Low: $3.45
High: $11.00

Volume

235,109 shs

Average Volume

425,418 shs

Market Capitalization

$703.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.8

Frequently Asked Questions

What sell-side analysts currently cover shares of CareMax?

The following Wall Street sell-side analysts have issued stock ratings on CareMax in the last year: Cowen Inc, Cowen Inc., Jefferies Financial Group Inc., Piper Sandler, and UBS Group AG.
View the latest analyst ratings for CMAX.

What is the current price target for CareMax?

5 Wall Street analysts have set twelve-month price targets for CareMax in the last year. Their average twelve-month price target is $11.40, suggesting a possible upside of 41.8%. Jefferies Financial Group Inc. has the highest price target set, predicting CMAX will reach $15.00 in the next twelve months. Cowen Inc. has the lowest price target set, forecasting a price of $8.00 for CareMax in the next year.
View the latest price targets for CMAX.

What is the current consensus analyst rating for CareMax?

CareMax currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CMAX will outperform the market and that investors should add to their positions of CareMax.
View the latest ratings for CMAX.

What other companies compete with CareMax?

How do I contact CareMax's investor relations team?

CareMax's physical mailing address is 780 THIRD AVENUE 37TH FLOOR, NEW YORK NY, 10017. The company's listed phone number is 786-360-4768 and its investor relations email address is [email protected] The official website for CareMax is www.caremax.com. Learn More about contacing CareMax investor relations.